SCHEMBL318519

SCHEMBL318519

CC(Br)CCCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27690106 1.00
SCHEMBL4655081 0.93 LMNA (0.52)
SCHEMBL3059051 0.93 LMNA (0.52)
SCHEMBL5848589 0.91 TSHR (0.55)
SCHEMBL1195012 0.91 TSHR (0.55)
SCHEMBL23854568 0.91 TSHR (0.55)
SCHEMBL11595992 0.91 TSHR (0.55)
SCHEMBL23829849 0.91 TSHR (0.55)
SCHEMBL5974021 0.91 TSHR (0.55)
SCHEMBL28582984 0.91 TSHR (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4735417-A1 IONIZABLE CATIONIC LIPID COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS Shanghai Vitalgen Biopharma Co., Ltd. (CN) 2026-05-06 EP disclosed
US-12582644-B2 O-GlcNAc transferase inhibitors and uses thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2026-03-24 US disclosed
WO-2025002399-A1 IONIZABLE CATIONIC LIPID COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS SHANGHAI VITALGEN BIOPHARMA CO., LTD. (CN) 2025-01-02 WO disclosed
WO-2025000542-A1 IONIZABLE CATIONIC LIPID COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS SHANGHAI VITALGEN BIOPHARMA CO., LTD. (CN) 2025-01-02 WO disclosed
US-12065605-B2 Liquid crystal composition, dichroic material, light absorption anisotropic film, laminate, and image display device FUJIFILM CORPORATION (JP) 2024-08-20 US disclosed
CN-117776923-A Crocetin diester compound and application thereof in liver cancer cell resistance 常州大学 2024-03-29 CN disclosed
CN-114890989-B HDAC8 degradation agent with nitrogenous derivative as Linker, preparation method and application thereof 广东晨康生物科技有限公司 2024-03-22 CN disclosed
CN-115385882-B Method for preparing delta-caprolactone 大连理工大学 2024-01-30 CN disclosed
CN-112209930-B Itratheophylline derivative, and preparation method and application thereof 山东新华制药股份有限公司 2023-05-16 CN disclosed
CN-113166116-B Amido bridged heterocyclic compound, and composition and application thereof 北京赛特明强医药科技有限公司 2022-12-27 CN disclosed
CN-1046166-A Contain the preparation method that the new 19-of 11 β-carbonated chain removes the first steroidal compounds ROUSSEL UCLAF (FR) 1990-10-17 CN disclosed
EP-0383579-A1 N-Phenyl-N-(4-piperidinyl)amides useful as analgesics GLAXO WELLCOME INC. (US) 1990-08-22 EP disclosed
WO-1990005719-A1 HYDROXAMIC ACID BASED COLLAGENASE INHIBITORS BRITISH BIO-TECHNOLOGY LIMITED (GB) 1990-05-31 WO disclosed
WO-1990005716-A1 HYDROXAMIC ACID BASED COLLAGENASE INHIBITORS BRITISH BIO-TECHNOLOGY LIMITED (GB) 1990-05-31 WO disclosed
US-4891363-A PLATELET ACTIVATING FACTOR ANTAGONISTS SANKYO COMPANY LIMITED (JP) 1990-01-02 US disclosed
EP-0157567-B1 CARBOXY-CONTAINING ESTER PRODRUGS OF CORTICOSTEROIDS THE UPJOHN COMPANY (US) 1989-11-29 EP disclosed
EP-0251827-A2 New cyclic ether derivatives, their preparation and their use Sankyo Company Limited (JP) 1988-01-07 EP disclosed
US-4588718-A ANTIINFLAMMATORY AGENTS THE UPJOHN COMPANY (US) 1986-05-13 US disclosed
EP-0157567-A2 Carboxy-containing ester prodrugs of corticosteroids THE UPJOHN COMPANY (US) 1985-10-09 EP disclosed
US-3953514-A Process for preparing cyclopentenone derivatives UBE INDUSTRIES, LTD. (JA) 1976-04-27 US disclosed